Otc - Active Ingredient
ACTIVE INGREDIENTS: TITANIUM DIOXIDE 4.7%, OCTINOXATE 2.2%
La Mer The Treatment Fluid Foundation
FDA Label NDC 65966-001
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Max Huber Research Lab Inc for the product La Mer The Treatment Fluid Foundation (NDC 65966-001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, warnings, otc - when using, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Warnings
WARNING: KEEP OUT OF EYES. IF IRRITATION PERSISTS, CONSULT A HEALTH CARE PRACTITIONER. KEEP OUT OF REACH OF CHILDREN.
Otc - When Using
DIRECTIONS: APPLY PRIOR TO SUN EXPOSURE
Package Label.Principal Display Panel
PRINCIPAL DISPLAY PANEL
LA MER
THE TREATMENT FLUID FOUNDATION
SPF 15
1.0 FL OZ/30 mL
MAX HUBER RESEARCH LAB INC.
NEW YORK, NY 10022
* Please review the disclaimer below.
